Latest Financial Results

Q2 2023

Quarterly Results

Ended Dec 31, 2022

Latest 10-K

Sign Up For E-Mail Alerts

Sign Up Today

Stock Information | View Detailed Stock Info

OTCQB: PPCB Propanc Biopharma, Inc.
Day Range
52 Week Range

Company Overview

Propanc is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ proenzymes, which are inactive precursors of enzymes.

View Scientific Whitepaper

IR Contact Information

Investor Relations

Propanc Biopharma, Inc.
T: +61-03-9882-6723

Transfer Agent

Action Stock Transfer
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: 801-274-1088
F: 801-274-1099